Technology Transfer Executives

  • Edward D. Zanders


The next three chapters are written as supplements to the main book, each being written for a defined group of professionals. This chapter focuses on university technology transfer managers and business development executives who offer their products and services to biopharmaceutical companies. Starting with a brief background to technology transfer and pharmaceuticals, the chapter provides a series of suggestions on how to prepare for a meeting with pharmaceutical executives and how to conduct the meeting itself. These suggestions are based on the author’s own experiences in dealing with these meetings from both sides of the negotiating table.


Pharmaceutical Company Technology Transfer Technology Transfer Office Biopharmaceutical Industry License Revenue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Finia R et al (2010) Inside or outside the IP system? Business creation in academia. Res Policy 39:1060–1069CrossRefGoogle Scholar
  2. MRC and therapeutic antibodies (2010). Accessed 4 Dec 2010
  3. NIH Office of Technology Transfer (2010). Accessed 4 Dec 2010
  4. Pielke R (2010) In retrospect: Science – the endless frontier. Nature 466:922–923CrossRefGoogle Scholar
  5. Rohrbaugh ML, Stanton BR (2009) Technology transfer at the National Institutes of Health. In: Ganguli P, Khanna R, Prickril B (eds) Technology transfer at the National Institutes of Health, in Technology transfer in biotechnology: a global perspective. Wiley-VCH, WeinheimGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.PharmaGuide LtdHertsUK

Personalised recommendations